“Keytruda is not for everyone,” says Dr. Anna Pavlick, Professor of Medicine and Dermatology at NYU Perlmutter Cancer Center. She often has patients request the immunotherapy drug in response to a commercial they’ve seen. However, it can be an effective immunotherapy, but in certain patients it may cause severe immune-related adverse effects. Some patients might need something stronger (or lighter) depending on a number of factors including where the melanoma is and how fast it’s spreading.
Learn more about SurvivorNet's rigorous medical review process.
Dr. Anna Pavlick is a medical oncologist and a Professor of Medicine and Dermatology at NYU Perlmutter Cancer Center. Read More
“Keytruda is not for everyone,” says Dr. Anna Pavlick, Professor of Medicine and Dermatology at NYU Perlmutter Cancer Center. She often has patients request the immunotherapy drug in response to a commercial they’ve seen. However, it can be an effective immunotherapy, but in certain patients it may cause severe immune-related adverse effects. Some patients might need something stronger (or lighter) depending on a number of factors including where the melanoma is and how fast it’s spreading.
Read More
